PARP1 and hypoparathyroidism-retardation-dysmorphism syndrome: PARP inhibitors captured PARP on the DNA of the single-strand break site, thereby preventing the repair of these breaks and producing double-strand breaks, which were not accurate in tumors with homologous recombination deficiency (HRD) repair [11].